Mifepristone in the treatment of the ectopic adrenocorticotropic hormone syndrome
© 2018 John Wiley & Sons Ltd Objectives: Mifepristone, a glucocorticoid receptor antagonist, can be used to manage hypercortisolism in patients with ectopic adrenocorticotropic hormone syndrome (EAS) when surgical cure is not feasible. Outcomes of EAS patients treated with mifepristone have be...
Saved in:
Main Authors: | Taweesak Wannachalee, Adina F. Turcu, Richard J. Auchus |
---|---|
Other Authors: | University of Michigan Medical School |
Format: | Article |
Published: |
2019
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/45016 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
The Clinical Impact of [<sup>68</sup>Ga]-DOTATATE PET/CT for the Diagnosis and Management of Ectopic Adrenocorticotropic Hormone – Secreting Tumours
by: Taweesak Wannachalee, et al.
Published: (2020) -
Developments in Primary Aldosteronism Subtyping Using Steroid Profiling
by: Taweesak Wannachalee, et al.
Published: (2020) -
Adrenal Vein Sampling Lateralization Despite Mineralocorticoid Receptor Antagonists Exposure in Primary Aldosteronism
by: Aya T. Nanba, et al.
Published: (2019) -
Three Discrete Patterns of Primary Aldosteronism Lateralization in Response to Cosyntropin during Adrenal Vein Sampling
by: Taweesak Wannachalee, et al.
Published: (2020) -
The Concordance Between Imaging and Adrenal Vein Sampling Varies With Aldosterone-Driver Somatic Mutation
by: Taweesak Wannachalee, et al.
Published: (2020)